Clinical Trial Details

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Categories (click each to see list of all clinical trials associated with that category): Pediatric (PEDONC)

Current Status: Open

Phase: N/A (Cancer Control)

Principal Investigator: Beck, Jill

Contact Information:
Angie Boettner
aboettner@unmc.edu

Eligibility: https://clinicaltrials.gov/study/NCT04726241?term=NCT04726241&rank=1

Summary
PRIMARY OBJECTIVES: I. To utilize clinical and biological characteristics of acute leukemias to screen for patient eligibility for available phase I/II Pediatric Acute Leukemia (PedAL) sub-trials. II. To maintain a longitudinal and comprehensive registry from relapse in children and young adults with recurrent and refractory leukemia.